Recherche avancée

Ken Tourangeau est vice-président exécutif de TFI International, Inc. Il est titulaire d'un diplôme de premier cycle de HEC Montral.

Actuellement, Ken Fisher occupe le poste de directeur de la technologie et de vice-président chez Kimco Realty Corp. Dans sa carrière antérieure, il a occupé le poste de directeur chez Deloitte & Touche LLP. M. Fisher a obtenu un diplôme de premier cycle à l'université Johns Hopkins et un diplôme d'études supérieures et un MBA à l'université de Floride.

Ken Kobayashi est membre du conseil d'administration de Mitsubishi Heavy Industries, Ltd, de Mitsubishi Motors Corp. et de Nissin Foods Holdings Co, Ltd, et président de Mitsubishi Corp.

Ken Nakajima formerly worked at Luckytex (Thailand) Public Co. Ltd., as Director, Thai Toray Textile Mills Public Co. Ltd., as Executive Director, Toray Textiles (Thailand) Public Co. Ltd., as Director & General Manager-Administration Division, and Toray Industries, Inc., as Manager-Finance & Control Department.

Ken Widner currently works at Casey's General Stores, Inc., as Vice President-IT Engineering.

Fondateur de ROHM Co, Ltd, Ken Sato siège au conseil d'administration de ROHM Co, Ltd. (ancien président et directeur représentatif) et président de la Rohm Music Foundation.

Ken Corless est vice-président exécutif chargé de la technologie, des offres et des partenaires chez DXC Technology Co. Il est titulaire d'un diplôme de premier cycle du Massachusetts Institute of Technology.

Ken Murphy is currently the Group Chief Executive Officer & Director at Tesco Plc, as well as a Director at Tesco Stores Ltd., Boots International Ltd., Soap & Glory Ltd., and Hatch Beauty LLC.
His former positions include Director at The Boots Co. Plc, Boots UK Ltd., and Liz Earle Beauty Co. Ltd., as well as Chief Commercial Officer & President-Global Brands at Walgreens Boots Alliance, Inc.

Actuellement, Ken Fujiwara est directeur et chef de la conformité chez Mitsubishi Chemical Holdings Corp. et chef de la direction de Mitsubishi Chemical Holdings Europe GmbH (une filiale de Mitsubishi Chemical Holdings Corp.). M. Fujiwara est également membre du conseil d'administration de Mitsubishi Tanabe Pharma Corp. Ken Fujiwara a précédemment occupé le poste de Chief Executive Officer de Mitsubishi Chemical Holdings America, Inc.

Ken Grady est Chief Information Officer & Senior VP chez IDEXX Laboratories, Inc. Au cours de sa carrière antérieure, M. Grady a occupé le poste de directeur de l'information chez New England Biolabs, Inc. et de responsable mondial de l'analyse commerciale chez Novartis Vaccines & Diagnostics, Inc. Il a obtenu un diplôme de premier cycle au Georgia Institute of Technology.

M. Ken Stillwell est directeur d'exploitation, directeur financier, directeur administratif et vice-président senior chez Pegasystems, Inc. Auparavant, M. Stillwell a été employé en tant que directeur financier et vice-président senior chez Dynatrace LLC, directeur financier de division chez PTC, Inc, directeur financier et vice-président des finances chez Inmedius, Inc, directeur de l'exploitation chez Milestone Group LLC, directeur chez Pricewaterhousecoopers LLC, et directeur financier et vice-président exécutif chez Sovos Compliance LLC. Il est titulaire d'un diplôme de premier cycle de l'université de Pittsburgh et d'un diplôme d'études supérieures de l'université de Caroline du Sud.

Ken Uchida occupe le poste de directeur, directeur général et directeur financier chez Kajima Corp. Par le passé, M. Uchida a occupé le poste de président et directeur de Kajima Europe Ltd.

Ken Hashimoto is an Independent Outside Director at TAKARA STANDARD CO., LTD.
since 2017.
He previously worked as Director, Head-Finance & Accounting at Kao Corp.
and as an Independent Non-Executive Outside Director at Itochu-Shokuhin Co., Ltd.

Ken Norgrove is currently the Chief Executive Officer & Director at RSA Insurance Group Ltd.
and the Chief Executive Officer at Scandi Co. 3 A, Trygg Hansa Försakring AB, and Royal & Sun Alliance Insurance Ltd.
He previously held positions as the Chief Executive Officer at RSA Insurance Group Ltd., Zurich Insurance Co., Codan Forsikring A, and RSA Insurance Ireland DAC.
He also served as a Director at Insurance Ireland, Vice President at Travelers Insurance Co. Ltd., and President at the Insurance Institute of Ireland.

Ken Takayama currently works at TechMatrix Corp., as Independent Outside Director from 2015 and Mercari, Inc., as Independent Outside Director from 2018.
Mr. Takayama also formerly worked at Rakuten Group, Inc., as CFO, Director & Investor Relations Contact in 2012, MEDIA DO Co., Ltd., as Independent Outside Director, Metaps, Inc., as Independent Outside Director, Star Festival, Inc., as Outside Director, and Mizuho Bank Ltd., as Principal.
Mr. Takayama received his Masters Business Admin degree in 1994 from The University of Texas at Austin and undergraduate degree from Hitosubashi University.

Actuellement, Ken Uehara est directeur, chef de l'audit et de la planification informatique chez Taisho Pharmaceutical Holdings Co., Ltd. et président de Biofermin Pharmaceutical Co., Ltd. et directeur représentatif et vice-président de Taisho Pharmaceutical Co., Ltd. (toutes deux sont des filiales de Taisho Pharmaceutical Holdings Co., Ltd.).

Ken Yamaguchi occupe le poste de Chief Medical Officer & Executive Vice President chez Centene Corp. Il était auparavant trésorier et directeur de l'American Academy of Orthopaedic Surgeons. Le Dr Yamaguchi est titulaire d'un MBA de l'université de Washington.

Ken Kutaragi currently holds the following positions: President, CEO & Representative Director at Cyber AI Entertainment, Inc.; Chief Executive Officer at Ascent Robotics, Inc.; Independent Outside Director at Rakuten Group, Inc.; Outside Director at SmartNews, Inc.; and Independent Outside Director at GA technologies Co., Ltd.
.
Mr. Kutaragi previously held the following positions: Chairman & Group Chief Executive Officer at Sony Interactive Entertainment, Inc. (Japan); Deputy President, COO & Director at Sony Group Corp.; Outside Director at Kadokawa Future Publishing KK; Independent Outside Director at Nojima Corp.; Independent Director at Marvelous, Inc.; and Outside Director at Kadokawa Magazines, Inc.

M. Ken Miyauchi est président de SoftBank Commerce & Services Corp. et président de SoftBank Corp. Il est membre du conseil d'administration de SoftBank Group Corp. Auparavant, M. Miyauchi a été employé en tant que directeur exécutif de Softbank Group Japan Godokaisha, président et directeur représentatif de WILLCOM, Inc., directeur des opérations, directeur représentatif et vice-président de Softbank Telecom Corp. et directeur externe de Carview Corp. et directeur des opérations, directeur représentatif et vice-président de SOFTBANK BB Corp. Il a également été membre du conseil d'administration de Brightstar Global Group, Inc, eAccess Ltd, Z Holdings Corp et Brightstar International Corp.

Ken Thomas is currently the Chief Information Officer at The Hain Celestial Group, Inc. He previously worked as the Chief Information Officer at McCormick & Co., Inc. He holds a Master's degree in Business Administration from Loyola University Maryland, Inc.

Ken Xie is the founder of Fortinet, Inc. (founded in 2000) and NetScreen Technologies, Inc. (founded in 1993).
He is currently the Chairman & Chief Executive Officer of Fortinet, Inc. Mr. Xie is also the founder of Stanford Infosystems International, Inc. Mr. Xie's current jobs include being a Director at Hua Yuan Science & Technology Association, a Director at Cyber Threat Alliance, a Member of the National Academy of Engineering, a Member of the Committee of 100, a Member of the Silicon Valley Leadership Group, a Member of The World Economic Forum USA, Inc. - Center of Cyber Security, and an Advisor at ForgePoint Capital Management LLC.
Mr. Xie's former jobs include being the Chief Executive Officer of Systems Integration Solutions, Inc., an Independent Director at TeleNav, Inc., a Director at ZingBox, Inc., a Principal at Emdeon Corp., and a Member - Center for Cybersecurity at Forum Mondial de L'Economie.
Mr. Xie's education includes a graduate degree from Stanford University and undergraduate and graduate degrees from Tsinghua University.

Ken Harris occupe le poste de directeur de l'information chez Shaklee Corp. Au cours de sa carrière passée, M. Harris a occupé le poste de directeur de l'exploitation et de l'information chez PepsiCo, Inc, de directeur de l'information et de vice-président senior chez NIKE, Inc et de directeur de l'information et de vice-président senior chez Gap, Inc. Il a obtenu un diplôme de premier cycle à l'université d'État du Colorado.

Actuellement, Ken K. Patel occupe le poste de Chief Ethics & Compliance Officer chez Procter & Gamble Co. M. Patel est également membre du conseil d'administration de la Mercantile Library of Cincinnati, de la Chambre de commerce de Cincinnati et de l'Uc College of Law, et président du Council of Better Business Bureaus, Inc. Il a obtenu un diplôme d'études supérieures de l'université de Cincinnati (Ohio) et un diplôme de premier cycle de l'université Purdue.

Ken Anderson is currently the Chief Finance Officer & Director at RSA Insurance Group Ltd.
He previously worked as a Safety Director at Genesee-Bay Constructors, Inc.

Le Dr Ken Takeshita, MD, est directeur mondial de la recherche et du développement chez Daiichi Sankyo Co, Ltd. Le Dr. Takeshita était auparavant employé en tant que Senior VP & Global Head-Clinical Development par Kite Pharma, Inc.

Ken Werner Østreng is currently the Chief Financial Officer at Kahoot!.
ASA since 2020.
Prior to this, he worked as a Director at Forsta Worldwide Ltd.
(United Kingdom) from 2006 to 2020.
He also worked as a Controller-Group Finance at Telenor ASA and as a Chief Financial Officer at Confirmit AS from 2005 to 2017.
Additionally, he served as the Chief Financial Officer at E-Line Group ASA. Mr. Østreng started his career as the Chief Financial Officer at Nagravision.
AS from 2003 to 2005.
He completed his undergraduate degree from the Norwegian School of Information Technology.

Anne Tourangeau has a current job as a Director at Virginia Land Title Association.

Michel k.
Tourangeau is currently a Director at Desjardins Trust, Inc. He previously held positions as Co-Secretary & Independent Director at The Fédération des caisses Desjardins du Québec, Independent Director at Capital Desjardins, Inc., Director at La Caisse Centrale Desjardins du Québec, and Director at Caisse Desjardins de Limoilou.

Serge Tourangeau is currently a Director at Desjardins Trust, Inc. He was previously an Independent Director at The Fédération des caisses Desjardins du Québec, a Director at Capital Desjardins, Inc., and an Independent Director at La Caisse Centrale Desjardins du Québec.

Maxime Tourangeau is currently the Director at LiveBarn, Inc. and a Partner at BDC Growth Equity Partners.
He is also a Board Observer at S.
Boudrias Horticole, Inc., a Board Member at 9208-0621 Québec, Inc., a Board Member at Media City, and a Board Member at Cognibox, Inc. In the past, Mr. Tourangeau served as a Board Member at Budge Studios, Inc. from 2014 to 2022, and as a Board Member at Intelcom Courrier Canada, Inc. from 2017 to 2019.
Mr. Tourangeau completed his undergraduate degree at HEC Montréal in 2005 and his graduate degree at Université du Québec à Montréal in 2009.

Kevin W.
Tourangeau is the founder.
He founded Randol Management Consultants LLC in 1988 and currently holds the title of Managing Partner.
In addition to his founding position, Mr. Tourangeau also held the position of Senior Vice President-Manufacturing Effectiveness at Conagra Brands, Inc.

Michel Tourangeau currently works as a Director at R.M.P.
Développements, Inc.

Gregory Tourangeau is currently working as the Chief Accounting Officer & VP-Finance at Fulcrum Therapeutics, Inc.

Ken Sagasa has a current job as a Managing Director at MBK Partners KK.

Ken Eichmann's current job(s) include being a Board Member at Quotient Sciences Ltd., a Partner at GHO Capital Partners LLP, a Board Member at Sanner GmbH, and a Board Member at Linimed Gruppe GmbH.
Mr. Eichmann's former job(s) include being an Associate at Citigroup, Inc., a Vice President at Odewald & Compagnie Gesellschaft für Beteiligungen mbH, a Principal at Stirling Square Capital Partners LLP, and an Analyst at Bank of America,.
NA (Private Banking).
Mr. Eichmann's education history includes completing his undergraduate degree at the University of Buckingham in 2003 and his graduate degree at Bayes Business School in 2004.

Mr. Ken Leslie is an Analyst at Goldwater Asset Management LP.
Mr. Leslie was previously employed as an Analyst by Suffolk Capital Management LLC, and Soros Fund Management LLC.
He was also employed as an Associate at New York Cancer Hospital and was a Research Technician at Gene Therapy Core Facility at Cornell University Medical School.
Mr. Leslie received his BA in Molecular Biology and Neuroscience degree from Kenyon College and his MBA in finance from Columbia University.

Ken Sato worked at Nagoya Railroad Co., Ltd.
from 1972 to 2012, where he held the position of Senior Managing Director.

Ken Pepple is the founder of Solinea, Inc. He previously worked as the Vice President-OpenStack Solutions at Cloud Technology Partners LLC.

Ken Morrow currently works as a Director-Pro Scouting for the New York Islanders Hockey Club LP.

Dr. Ken Shimokawa is Senior Investment Director at Astellas Venture Management LLC.
Prior to joining AVM in March 2011, Dr. Shimokawa served as an Associate Director at Department of Licensing & Alliances, Astellas Pharma Inc since October 2010.
He was involved M&A of Japanese Biotech Company, a license-in deal opportunity as well as evaluation of a couple of license-in opportunities.
During 2006-2010, he served as a Global Project Leader for CNS and bone therapeutic area at Project Management, Development, Astellas Pharma Inc. He brought “Bonoteo” for osteoporosis drug in Japanese market, as well as staged up a couple of compounds to P2/3, P1 and P0 in US/EU/JP.
Prior to the GPL, Dr. Shimokawa served as a medicinal and combinatorial chemist to synthesize number of compounds for various therapeutic areas, especially for CNS, Pain and Cardiovascular.
Dr. Shimokawa received a Ph.D.
in Organic Chemistry from the University of Pennsylvania in 1995.

Ken Emery is a professional with a doctorate degree from the University of California, Los Angeles, an undergraduate degree from Colby College, and a graduate degree from the London School of Economics & Political Science.
He is currently a Senior Vice President at Moody's Investors Service, Inc. since 2003.
Prior to this, he worked as a Director at Deutsche Bank Corp.
from 2000 to 2003, as a Vice President at Associates First Capital Corp.
from 1996 to 1999, and as a Senior Economist & Policy Advisor at the Federal Reserve Bank of Dallas from 1990 to 1995.

Ken Heikkila worked as a Principal at King County School District No.
406 and King County School District No.
415 in Washington.
He also served as Board President at Encompass Northwest from 2013 to 2014.
He holds an undergraduate degree from Carleton College, a graduate degree from Vanderbilt University, and a doctorate from Seattle University.

Ken M.
Link is currently the Chief Operating Officer at Latitude Energy Services LLC.
Previously, he worked as the Secretary & Treasurer at Latitude Solutions, Inc.

Ken Clark is currently the General Manager at Irondale Industrial Contractors, Inc. He previously worked as a Project Manager at BE&K, Inc. and as an Operations Manager at PegasusTSI, Inc. He received an undergraduate degree from Auburn University.

Ken Skoog founded Stracton AB, where he worked as Chief Executive Officer.
Mr. Skoog also currently works at Mercuri International Group AB, as Director from 2019.
Mr. Skoog also formerly worked at Salesonly AB, as Chief Executive Officer, Shortcut Media AB, as Director, K2 Search AB, as Sales Manager & Vice President, Wise Group AB, as Sales Manager from 2004 to 2014, and Top of Heart AB, as Partner.
Mr. Skoog received his graduate degree from the University of Stockholm.

Ken Wilczek is currently the Vice President-Sales & Marketing at BiOptix Diagnostics, Inc. He previously worked as an Associate Director at Johnson & Johnson, General Manager at IHS Health Group, General Manager-Antibodies Research at Thermo Fisher Scientific, Inc., and President at Affinity BioReagents, Inc. Mr. Wilczek has a graduate degree from Thunderbird School of Global Management and an undergraduate degree from the University of Denver.